Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

sandoz new zealand limited - ceftazidime pentahydrate 582.4mg equivalent to 500 mg ceftazidime - powder for injection - 500 mg - active: ceftazidime pentahydrate 582.4mg equivalent to 500 mg ceftazidime excipient: nitrogen sodium carbonate - ceftazidime sandoz is indicated for the treatment of single or multiple infections caused by susceptible organisms. may be used alone as first choice medicine before the results of sensitivity tests are available. may be used in combination with an aminoglycoside or most other beta-lactam antibiotics. may be used with an antibiotic against anaerobes when the presence of bacteroides fragilis is suspected. indications include: severe infections e.g. septicaemia, bacteraemia, peritonitis, meningitis; infections in immunosuppressed patients; infections in patients in intensive care, e.g. infected burns; respiratory tract infections including lung infections in cystic fibrosis; ear, nose and throat infections; urinary tract infections; skin and soft tissue infections; gastrointestinal, biliary and abdominal infections; bone and joint infections; infections associated with haemo-and peritoneal dialysis and with continuous ambulatory peritoneal dialysis (capd).

Iisrael - inglise - Ministry of Health

neopharm (israel) 1996 ltd - ceftazidime as pentahydrate - powder for solution for injection - ceftazidime as pentahydrate 1000 mg/vial - ceftazidime - ceftazidime is indicated for the treatment of the infections listed below in adults and children includingneonates (from birth).• nosocomial pneumonia• broncho-pulmonary infections in cystic fibrosis• bacterial meningitis• chronic suppurative otitis media• malignant otitis externa• complicated urinary tract infections• complicated skin and soft tissue infections• complicated intra-abdominal infections• bone and joint infections• peritonitis associated with dialysis in patients on capd.treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (turp).the selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic gram negative bacteria (see sections 4.4 and 5.1).ceftazidime should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum of activity.consideration should be given to official guidelines regarding the appropriate use of antibacterial agents

Iisrael - inglise - Ministry of Health

neopharm (israel) 1996 ltd - ceftazidime as pentahydrate - powder for solution for inj/inf - ceftazidime as pentahydrate 2000 mg/vial - ceftazidime - ceftazidime is indicated for the treatment of the infections listed below in adults and children includingneonates (from birth).• nosocomial pneumonia• broncho-pulmonary infections in cystic fibrosis• bacterial meningitis• chronic suppurative otitis media• malignant otitis externa• complicated urinary tract infections• complicated skin and soft tissue infections• complicated intra-abdominal infections• bone and joint infections• peritonitis associated with dialysis in patients on capd.treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing trans-urethral resection of the prostate (turp).the selection of ceftazidime should take into account its antibacterial spectrum, which is mainly restricted to aerobic gram negative bacteria (see sections 4.4 and 5.1).ceftazidime should be co-administered with other antibacterial agents whenever the possible range of causative bacteria would not fall within its spectrum of activity.consideration should be given to official guidelines regarding the appropriate use of antibacterial agents

Iisrael - inglise - Ministry of Health

pharmalogic ltd - ceftazidime as pentahydrate - powder for solution for inj/inf - ceftazidime as pentahydrate 1 g - ceftazidime - ceftazidime panpharma is indicated for the treatment of the infections listed below in adults and children including neonates (from birth). - nosocomial pneumonia- broncho-pulmonary infections in cystic fibrosis- bacterial meningitis- chronic supportive otitis media- malignant otitis externa- complicated urinary tract infections- complicated skin and soft issues infections- complicated intra-abdominal infections- bone and joint infections- peritonitis associated with dialysis in patients with capdtreatment of patients with bacteremia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing transurethral resection of the prostate (turp).

Iisrael - inglise - Ministry of Health

pharmalogic ltd - ceftazidime as pentahydrate - powder for solution for inj/inf - ceftazidime as pentahydrate 2 g - ceftazidime - ceftazidime panpharma is indicated for the treatment of the infections listed below in adults and children including neonates (from birth). - nosocomial pneumonia- broncho-pulmonary infections in cystic fibrosis- bacterial meningitis- chronic supportive otitis media- malignant otitis externa- complicated urinary tract infections- complicated skin and soft issues infections- complicated intra-abdominal infections- bone and joint infections- peritonitis associated with dialysis in patients with capdtreatment of patients with bacteremia that occurs in association with, or is suspected to be associated with, any of the infections listed above.ceftazidime may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.ceftazidime may be used in the peri-operative prophylaxis of urinary tract infections for patients undergoing transurethral resection of the prostate (turp).

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ceftazidime pentahydrate -

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - ceftazidime pentahydrate -

Malta - inglise - Medicines Authority

hospira uk limited horizon, honey lane, hurley, maidenhead sl6 6rj, united kingdom - ceftazidime pentahydrate - powder for solution for infusion or injection - ceftazidime pentahydrate 1.165 g - antibacterials for systemic use

Malta - inglise - Medicines Authority

hospira uk limited horizon, honey lane, hurley, maidenhead sl6 6rj, united kingdom - ceftazidime pentahydrate - powder for solution for injection/infusion - ceftazidime pentahydrate 2.330 g - antibacterials for systemic use

Malta - inglise - Medicines Authority

pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - ceftazidime pentahydrate - powder for solution for injection - ceftazidime pentahydrate 500 milligram(s) - antibacterials for systemic use